Boehringer Ingelheim expands animal health portfolio in India market with two new drugs launches Read more
Biocon Biologics to get Rs 225 cr from Tata Capital Growth Fund for 0.85 per cent equity stake Read more
Govt gives validity extension of six months on registration certificate to pharma companies Read more
Biocon and Voluntis deal to transform insulin biosimilars personalised care through digital therapeutics: GlobalData Read more